Detalles de la búsqueda
1.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791162
2.
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
J Infect Dis
; 229(2): 367-375, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37531657
3.
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.
Antimicrob Agents Chemother
; 68(5): e0158723, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534112
4.
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Clin Infect Dis
; 70(1): 1-10, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125055
5.
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years.
BMC Infect Dis
; 20(1): 426, 2020 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32552685
6.
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
Clin Infect Dis
; 67(1): 42-49, 2018 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29324986
7.
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
N Engl J Med
; 372(12): 1114-25, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25785969
8.
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Clin Infect Dis
; 65(5): 787-795, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017280
9.
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia.
Eur Respir J
; 42(5): 1283-90, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23397295
10.
Candidate odours for a short form odorant identification test.
Eur Arch Otorhinolaryngol
; 270(10): 2663-6, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23389328
11.
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children.
Vaccine
; 41(5): 1153-1160, 2023 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621408
12.
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.
Vaccine
; 41(50): 7548-7559, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977942
13.
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.
Vaccine
; 40(49): 7014-7021, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283896
14.
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Vaccine
; 39(40): 5991-6003, 2021 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483022
15.
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
Vaccine
; 38(27): 4236-4245, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389497
16.
Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine.
Hum Vaccin Immunother
; 16(6): 1272-1279, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32401600
17.
Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children.
Vaccine
; 38(22): 3902-3908, 2020 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32284274
18.
Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age.
Hum Vaccin Immunother
; 16(6): 1280-1291, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32598244
19.
'Perhaps a Bit Different to What We Did Twenty Years Ago': Senior Teachers' Perceptions of Outdoor Adventure within Primary Education in England.
Sports (Basel)
; 7(4)2019 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010210
20.
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
Vaccine
; 37(19): 2600-2607, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962095